Episode 273: Navigating FDA Regulation for Life Sciences Companies with Christin Carey of Maynard Nexsen
About this episode
Christin Carey discusses FDA regulation and its impact on life sciences and digital health industries.
Heather and Matthew welcome Christin Carey, Maynard Nexsen’s newest FDA‑focused life sciences attorney, for a discussion on regulatory developments shaping the life sciences and digital health industries. Drawing on her extensive experience advising companies on FDA compliance and her recent in‑house role at Amazon Health Services, Christin shares insight on new tariffs affecting pharma and biotech, evolving FDA guidance for digital health and clinical decision support tools, and the agency’s approach to AI, cybersecurity, and emerging technologies. Tune in for valuable guidance on navigating FDA regulation while developing innovative health products.
More episodes of Taking the Pulse: a Health Care and Life Sciences Podcast
- Episode 278: Equipping Health Systems with the Right AI Solutions with Dr. Mark Sendak of Vega Health
- Episode 277: M&A Trends and Growth in the Life Sciences Industry with John Erwin of Maynard Nexsen
- Episode 276: Educating the Life Sciences Workforce with Wake Tech’s Leslie Isenhour
- Episode 274: Advancing Cancer Immunotherapy with Dr. Besim Ogretmen of Lipo‑Immuno Tech & MUSC
- Episode 272: Humanism and Transplant Care with Dr. Joseph Scalea of MUSC
- Episode 271: Advancing Neurotrauma Treatments with Ken Webb of NeuroHope Therapeutics
Explore listener stats, chart rankings, contacts and more on the Taking the Pulse: a Health Care and Life Sciences Podcast podcast page.